Please select an option below to help us tailor your newsletter to best suit your content interests!
West Fight On returns to Shelby Farms Park on September 11, 2021 Get ready to cycle, run, or walk to beat cancer! West Fight On benefiting West Cancer Foundation will be LIVE and IN-PERSON this September! This signature fundraising event will return to its home at Shelby Farms Park on Saturday, September 11,… Read more »
Here at West Cancer Center & Research Institute, we are proud to host our own virtual tumor boards, or Multidisciplinary Conferences, multiple times each week. In these multidisciplinary conferences, we bring together a variety of providers from different disciplines and even institutions to talk about patient cases. It is in these conferences that a group… Read more »
Dr. Daniel Vaena, Director of Experimental Therapeutics Program at West Cancer Center Research Institute, co-presented updated data from Compugen Ltd.’s Phase 1 dose escalation and expansion study of COM701 as a monotherapy, and in a dose escalation combination study with Opdivo® (nivolumab) Vaena states “Although these results are very preliminary, they suggest that targeting… Read more »
It is with great excitement that our West Cancer Center and Research Institute network adds a new leadership role to our Division of Pharmacy. Camille Hill, PharmD has recently accepted a newly created role of Vice President of Oncology Pharmacy Services, which has become a vital aspect for our network as West continues to grow…. Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
West Cancer Center Palliative Care Physician, Dr. W. Clay Jackson, recently co-authored a case report alongside fellow, Jessica Rich, DO, published in Consultant 360. The two detail a patient case regarding pain in a man with opioid-use-disorder who is taking medication assisted therapy. Pain in a Man With Opioid Use Disorder Who Is Taking… Read more »
New technology and treatments for cancer are ever changing. Researching and providing innovative, curative therapies are a top priority at West Cancer Center. Now women managing cervical cancer will have access to MRI-guided brachytherapy treatment as an option – first available in the MidSouth, right here at West. According to the American Cancer Society, cervical… Read more »
Our West family is proud to have several of our oncologists publish research being presented at the upcoming American Society of Clinical Oncology Meeting, taking place June 4 – 8. West Cancer Center doctors Schwartzberg, Grothey, A. VanderWalde, Vaena, Vidal and ElNaggar are some of the renowned physicians being recognized at this esteemed event for… Read more »
Advancing Cancer Care from the United States to Uzbekistan Just 30 years ago, nearly 27% of hospitals in the country of Uzbekistan didn’t have sewage systems and 17% didn’t even have access to running water. Since the country’s independencefrom Russia in 1991, Uzbekistan has made drastic improvements to its healthcare system to better serve its… Read more »